Tiếng Việt
Native Phospholipid Platform
Our Core Platform
A proprietary phospholipid platform designed to preserve the native complexity of phospholipids, creating the foundation for regenerative medicine and next-generation therapeutic delivery.
Why This Platform
Every biological system begins with membranes.
Phospholipids are among the most fundamental structural components of living cells, playing essential roles in membrane integrity, cellular communication, and tissue homeostasis.
At DKD, we believe preserving the native biological characteristics of phospholipids creates opportunities beyond conventional excipients—building a platform that works with biology rather than simply delivering molecules.
Native Biological Origin
Derived from egg-yolk phospholipids while preserving their native biological complexity.
Solvent-Free Manufacturing
Developed without the intentional use of organic solvents or synthetic surfactants.
Biological Compatibility
Designed to interact naturally with biological membranes and damaged tissues.
Platform Technology
One proprietary platform supporting multiple therapeutic directions.
Platform Philosophy
Our approach is not to replace biology, but to work with it.
Rather than simplifying phospholipids into isolated components, DKD seeks to preserve their native biological complexity and translate it into practical biomedical applications.
This philosophy guides every stage of development—from manufacturing and formulation to clinical translation.
How the Platform Works
The DKD platform combines phospholipid chemistry with biological compatibility to support both active-compound delivery and tissue interaction.
Biological Organization
The amphiphilic phospholipid structure enables the spontaneous organization of bioactive compounds into stable nano-scale assemblies.
Enhanced Delivery
Supports the protection and transport of active compounds across biological barriers while improving local bioavailability.
Biological Interaction
Interacts with cellular membranes and supports biological processes associated with tissue repair and regeneration.
Protective Microenvironment
Helps maintain a physiological lipid environment that supports hydration, membrane stability, and tissue recovery.
From Platform to Clinical Translation
The first clinical translation of the DKD phospholipid platform has been achieved in wound healing and tissue regeneration.
This application has been commercialized as a Class B medical device in Vietnam and represents the first real-world validation of the broader platform.
Rather than being the destination, wound care serves as the starting point for expanding the platform into additional therapeutic fields.
Lead Clinical Platform
Wound Healing & Tissue Regeneration
- Commercialized Medical Device
- Real-world clinical experience
- Hospital applications
- Protected by U.S. and Vietnamese patents
Platform Expansion
The same phospholipid platform is being translated into additional biomedical applications through specialized development programs.